Cellular and molecular actions displayed by estrone on vascular endothelium

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 136-143

  Rauschemberger, M Belén ^a,b   Sandoval, Marisa J ^a,c   Massheimer, Virginia L ^a,b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b Consejo Nacional de Investigaciones Científicas y Técnicas ^*  (Argentina)

^c UNIVERSIDAD TECNOLÓGICA NACIONAL   (Argentina)

Author keywords

Adhesion molecules; Apoptosis; Cell proliferation; Estrone; Nitric oxide

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; LEUKOCYTE ADHERENCE; MESSENGER RNA SYNTHESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; AORTA; APOPTOSIS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA FRAGMENTATION; DNA REPLICATION; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EQUILIN; ESTRADIOL; ESTRONE; FEMALE; LEUKOCYTES, MONONUCLEAR; NITRIC OXIDE; RATS; RATS, WISTAR; THYMIDINE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79958071591     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.009     Document Type: Article

References (46)

1. Bachetti T., Morbidelli L. Endothelial cells in culture: a model for studying vascular functions. Pharmacol. Res. 2000, 42:9-19.
2. Bulun S., Zeitaum K., Sasano H., Simpson E. Aromatase in aging women. Semin. Reprod. Endocrinol. 1999, 17:349-358.
3. Callera G.E., Montezano A.C., Touyz R.M., Teixeira S., Muscara M.N., Carvalho M.H., Fortes Z., Nigro D., Schiffrin E., Tostes R. ETA receptor mediates altered leukocyte endothelial cell interaction and adhesion molecules expression in DOCA-salt rats. Hypertension 2004, 43:872-879.
4. Cartwright J.E., Johnstone A.P., Whitley G.S. Endogenously produced nitric oxide inhibits endothelial cell growth as demonstrated using novel antisense cell lines. Br. J. Pharmacol. 2000, 131:131-137.
5. Chambliss K.L., Yuhanna I.S., Mineo C., Liu P., German Z., Sherman T.S., Mendelsohn M.E., Anderson R.G., Shaul P.W. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res. 2000, 87:E44-E52.
6. Choy J.C., Granville D.J., Hunt D.W., McManus B. Endothelial cell apoptosis: biochemical characteristics and potencial implications for atherosclerosis. J. Mol. Cell Cardiol. 2001, 33:1673-1690.
7. Cronstein B., Kimmele S., Levin R., Martiniuk F., Weissman G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:9991-9995.
8. Cutini P., Sellés J., Massheimer V. Cross-talk between rapid and long term effects of progesterone on vascular tissue. J. Steroid Biochem. Mol. Biol. 2009, 115:36-43.
9. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 2000, 52:513-556.
10. Fu X.D., Cui Y.H., Lin G.P., Wang T.H. Non-genomic effects of 17beta-estradiol in activation of the ERK1/ERK2 pathway induces cell proliferation through upregulation of cyclin D1 expression in bovine artery endothelial cells. Gynaecol. Endocrinol. 2007, 23:131-137.
11. Geraldes P., Sirois M.G., Bernatchez P.N., Tanguay J.F. Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1585-1590.
12. Geraldes P., Sirois M.G., Tanguay J.F. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ. Res. 2003, 93:399-405.
13. Grow D.R. Metabolism of endogenous and exogenous reproductive hormones. Obstet. Gynaecol. Clin. North Am. 2002, 29:425-436.
14. Gruber C.J., Tschugguel W., Schneeberger C., Huber J.C. Production and actions of estrogens. N. Engl. J. Med. 2002, 346:340-352.
15. Jung U., Ley K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J. Immunol. 1999, 162:6755-6762.
16. Kappert K., Caglayan E., Huntgeburth M., Bäumer A.T., Sparwel J., Uebel M., Rosenkranz S. 17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H538-H546.
17. Kockx M.M., Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc. Res. 2000, 45:736-746.
18. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
19. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., Suzaki Y., Abe S., Hasegawa T., Tamaki T. Antioxidants inhibit endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem. Pharmacol. 2002, 64:1521-1531.
20. Lösel R., Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 2003, 4:46-56.
21. Lösel R., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 2003, 83:965-1016.
22. Massheimer V., Polini N., Benozzi S., Alvarez C., Sellés J. Rat aorta rapid response to estrone and estradiol are mediated by different mechanisms. Rev. Arg. Endocrinol. Metabol. 2003, 40:1-12.
23. Massheimer V., Polini N., Alvarez C., Benozzi S., Rauschemberger M.B., Sellés J. Signal transduction pathways involved in non-genomic action of estrone on vascular tissue. Steroids 2006, 71:857-864.
24. Mendelsohn M., Karas R. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340:1801-1811.
25. Meyer M.R., Haas E., Prossnitz E.R., Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell Endocrinol. 2009, 308:9-16.
26. Miller V.M., Duckles S.P. Vascular actions of estrogens: functional implications. Pharmacol. Rev. 2008, 60:210-241.
27. Motylewska E., Melén-Mucha G. Estrone and progesterone inhibit the growth of murine MC38 colon cancer line. J. Biochem. Mol. Biol. 2009, 113:75-79.
28. Murakami H., Harada N., Sasano H. Aromatase in atherosclerotic lesions of human aorta. J. Steroid Biochem. Mol. Biol. 1999, 79:67-74.
29. Notelovitz M. Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause. Med. Gen. Med. 2006, 8:85.
30. Ohtsuka M., Miyashita Y., Shirai K. Lipids deposited in human atheromatous lesions induce apoptosis of human vascular smooth muscle cells. J. Atheroscler. Thromb. 2006, 13:256-262.
31. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989, 59:1203-1211.
32. Pawlowski N.A., Abraham E.L., Pontier S., Scott W., Cohn Z.A. Human monocyte-endothelial cell interaction in vitro. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:8208-8212.
33. Pedram A., Razandi M., Aitkenhead C., Hughes C.C.W., Levin E.R. Integration of the non-genomic and genomic actions of estrogen. J. Biol. Chem. 2002, 277:50768-50775.
34. Pedram A., Razandi M., Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 2006, 20:1996-2009.
35. Peng L.V., Shelley C.P., Yanjv X., Liu S., Hesheng L. Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis. Mediators Inflamm. 2006, 2006:1-10.
36. Rao R.M., Yang L., García-Cardena G., Luscinkas F. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 2007, 101:234-247.
37. Rasband W. Image J 1. 43 c Version - Image Processing and Analysis in Java 2004, National Institutes of Health, Bethesda, available at http://rsb.info.nih.gov/ij/.
38. Rauschemberger M.B., Sellés J., Massheimer V. The direct action of estrone on vascular tissue involves genomic and non-genomic actions. Life Sci. 2008, 82:115-123.
39. Sandoval M.J., Cutini P.H., Rauschemberger M.B., Massheimer V.L. The soyabean isoflavone genistein modulates endothelial cell behaviour. Br. J. Nutr. 2010, 104:171-179.
40. Sasson S., Notides A.C. Estriol and estrone interaction with the estrogen receptor. II. Estriol and estrone-induced inhibition of the cooperative binding of [3H]estradiol to the estrogen receptor. J. Biol. Chem. 1983, 258:8118-8122.
41. Sawicki M., Erman M., Puranen T., Vihko P., Ghosh D. Structure of the ternary complex of human 17 beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:840-845.
42. Sellés J., Polini N., Alvarez C., Massheimer V. Novel action of estrone on vascular tissue: regulation of NOS and COX activity. Steroids 2005, 70:251-256.
43. Simoncini T. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric 2009, 12(Suppl. 1):6-11.
44. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrinol. Rev. 1993, 14:459-479.
45. Watson C., Jeng Y., Kochukov M. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signalling and proliferation. FASEB J. 2008, 22:3328-3336.
46. Wehling M., Lösel R. Non-genomic steroid hormone effects: membrane or intracellular receptors?. J. Steroid Biochem. Mol. Biol. 2006, 102:180-183.